SCVE 10-K & 10-Q changes, risk factors and insider trading
Sound Cave Technology Inc. · OTC · Miscellaneous Fabricated Textile Products · CIK 1912540 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
We are a smaller reporting company and not required to include this disclosure in our Form 10-K annual report.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“During the year ended December 31, 2023, the Company received $5,700 of share subscriptions relating to a private placement of common shares at $0.05 per share. On May 19, 2021, the company issued a total of 10,000,000 common shares to its founder and director, Christopher Campbell for services provided to the Company, valued at a price of $0.001 per share.”see in full comparison
“During the year ended December 31, 2024, the Company received proceeds of $45,138 from our Director towards the operating expenses. During the year ended December 31, 2023, the Company received proceeds of $100 from our Director towards the operating expenses and paid $1,600 to our President and Director for repayment of related party dues.”see in full comparison
“During the year ended December 31, 2025, the Company received proceeds of $59,854 from our Director towards the operating expenses and Proceeds from common stock of $200. During the year ended December 31, 2024, the Company received proceeds of $45,138 from our Director towards the operating expenses.”see in full comparison
As of December 31,see in full comparison2024,2025, the Company had a cashbalancebalance, advances and total assets of$1,332$1,599 compared to cash and total assets of$1,463$1,332 as at December 31,2023.2024. The decrease in cash and total assets was due to the proceeds received from the share subscriptions being used to pay day-to-day operating costs. As at December 31,20242025 and2023,2024, we had total liabilities of$61,220$128,036 and$12,457$61,220 respectively. Our working capital deficit was $126,437 as at December 31, 2025 compared to $59,888 as at December 31,2024 compared to $10,994 as at December 31, 2023.2024.
“During the year ended December 31, 2024, and 2023, the Company received $0 and $5,700 share subscriptions relating to a private placement of common shares at $0.05 per share respectively.”see in full comparison
During the year ended December 31,see in full comparison2024,2025, we incurred$48,894$66,749 of operating expenditure comprised of general administration expenses, and professional fees compared to$2,993$48,894 for the year ended December 31,2023,2024, forelectric components and fabric,general administration expenses, professional fees. The increase in operating expenses is due to an increase in operating activity during the current period, including professional. Our accumulated deficit is $(82,167148,916) and we have not earned any revenue since our inception.
Full comparison: every changed paragraph (6)
During the year ended December 31, 2024,2025, we incurred $48,894$66,749 of operating expenditure comprised of general administration expenses, and professional fees compared to $2,993$48,894 for the year ended December 31, 2023,2024, for electric components and fabric, general administration expenses, professional fees. The increase in operating expenses is due to an increase in operating activity during the current period, including professional. Our accumulated deficit is $(82,167148,916) and we have not earned any revenue since our inception.
During the year ended December 31, 2023, the Company received $5,700 of share subscriptions relating to a private placement of common shares at $0.05 per share. On May 19, 2021, the company issued a total of 10,000,000 common shares to its founder and director, Christopher Campbell for services provided to the Company, valued at a price of $0.001 per share.
As of December 31, 2024,2025, the Company had a cash balancebalance, advances and total assets of $1,332$1,599 compared to cash and total assets of $1,463$1,332 as at December 31, 2023.2024. The decrease in cash and total assets was due to the proceeds received from the share subscriptions being used to pay day-to-day operating costs. As at December 31, 20242025 and 2023,2024, we had total liabilities of $61,220$128,036 and $12,457$61,220 respectively. Our working capital deficit was $126,437 as at December 31, 2025 compared to $59,888 as at December 31, 2024 compared to $10,994 as at December 31, 2023.2024.
During the year ended December 31, 2025, the Company received proceeds of $59,854 from our Director towards the operating expenses and Proceeds from common stock of $200. During the year ended December 31, 2024, the Company received proceeds of $45,138 from our Director towards the operating expenses.
During the year ended December 31, 2024, the Company received proceeds of $45,138 from our Director towards the operating expenses. During the year ended December 31, 2023, the Company received proceeds of $100 from our Director towards the operating expenses and paid $1,600 to our President and Director for repayment of related party dues.
During the year ended December 31, 2024, and 2023, the Company received $0 and $5,700 share subscriptions relating to a private placement of common shares at $0.05 per share respectively.
What changed in the latest 10-Q
Risk Factors
In addition to other information set forth in this report, you should carefully consider the risk factors described in our Registration Statement on Form S-1, which was declared effective on May 13, 2022. Those factors could materially affect our business, financial condition or future results. In addition, risks and uncertainties not currently known to us or that we currently deem to be immaterial may also have a materially adverse effect on our business, financial condition and/or operating results.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
New heading “For the six months ended June 30, 2026 and 2025”
Largest changes
“During the three months ended March 31, 2026, we incurred $15,896 of operating expenditure comprised of general and administrative expenses of $2,146 and professional fees of $13,750. During the three months ended March 31, 2025, we incurred $17,358 of operating expenditure comprised of general and administrative expenses of $3,408 and professional fees of $13,950.”see in full comparison
“During the three months ended June 30, 2026, we incurred $12,968 of operating expenditure comprised of general and administrative expenses of $3,018 and professional fees of $9,950. During the three months ended June 30, 2025, we incurred $7,658 of operating expenditure comprised of general and administrative expenses of $(1,842) and professional fees of $9,500.”see in full comparison
“During the six months ended June 30, 2026, we incurred $28,864 of operating expenditure comprised of general and administrative expenses of $5,164 and professional fees of $23,700. During the six months ended June 30, 2025, we incurred $25,016 of operating expenditure comprised of general and administrative expenses of $1,566 and professional fees of $23,450.”see in full comparison
During thesee in full comparisonthreesix months endedMarchJune31,30, 2026, net cash provided by financing activities is$12,463.$28,048. Company received$12,463$28,048 from the President and Director towards Company operating expenses. During thethreesix months endedMarchJune3130 2025, net cash provided by financing activities of$11,025.$29,025. Company received$11,025$29,025 from the President and Director towards Company operating expenses.
During thesee in full comparisonthreesix months endedMarchJune31,30, 2026, we used$12,496$28,114 cash for operating activities. For thethreesix months endedMarchJune3130 2025, we used$11,058.$29,091.
Full comparison: every changed paragraph (10)
As of MarchJune 31,30, 2026, we had a cash balance and total assets of $1,566$1,533 compared to cash and total assets of $1,599 as of December 31, 2025. The increase in cash and total assets was due to a increase in advance and a decrease in financing and operating activity. As of MarchJune 31,30, 2026, and December 31, 2025, we had total liabilities of $143,899$156,834 and $128,036 respectively. The increase in liabilities was due to related parties payments.
Our working capital deficit was $142,333$155,301 as of MarchJune 31,30, 2026 compared to $126,437 as of December 31, 2025. The increase in the working capital deficit was due to the decrease in cash balance as of MarchJune 31,30, 2026.
For the three months ended MarchJune 31,30, 2026 and 2025
During the three months ended June 30, 2026, we incurred $12,968 of operating expenditure comprised of general and administrative expenses of $3,018 and professional fees of $9,950. During the three months ended June 30, 2025, we incurred $7,658 of operating expenditure comprised of general and administrative expenses of $(1,842) and professional fees of $9,500.
For the six months ended June 30, 2026 and 2025
During the six months ended June 30, 2026, we incurred $28,864 of operating expenditure comprised of general and administrative expenses of $5,164 and professional fees of $23,700. During the six months ended June 30, 2025, we incurred $25,016 of operating expenditure comprised of general and administrative expenses of $1,566 and professional fees of $23,450.
During the three months ended March 31, 2026, we incurred $15,896 of operating expenditure comprised of general and administrative expenses of $2,146 and professional fees of $13,750. During the three months ended March 31, 2025, we incurred $17,358 of operating expenditure comprised of general and administrative expenses of $3,408 and professional fees of $13,950.
During the threesix months ended MarchJune 31,30, 2026, we used $12,496$28,114 cash for operating activities. For the threesix months ended MarchJune 3130 2025, we used $11,058.$29,091.
During the threesix months ended MarchJune 31,30, 2026, net cash provided by financing activities is $12,463.$28,048. Company received $12,463$28,048 from the President and Director towards Company operating expenses. During the threesix months ended MarchJune 3130 2025, net cash provided by financing activities of $11,025.$29,025. Company received $11,025$29,025 from the President and Director towards Company operating expenses.
The financial statements as of and for the threesix months ended MarchJune 31,30, 2026 included herein, which have not been audited pursuant to the rules and regulations of the Securities and Exchange Commission, reflect all adjustments which, in the opinion of management, are necessary for a fair presentation of financial position, results of operations and cash flows for the interim periods on a basis consistent with the annual audited statements. All such adjustments are of a normal recurring nature. The results of operations for interim periods are not necessarily indicative of the results that may be expected for any other interim period or for a full year. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented not misleading.
SCVE insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding SCVE (13F)
None of the 59 investors we track reported a position in their latest 13F.